CCEL
CryoCell International Inc
4.10$
-3.6%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.1% | -0.3% | +2.4% | +0.3% | -0.5% | -0.7% | -0.5% | -1.3% | +0.2% | -2.0% | +1.2% | – | |
| – | -3.7% | -0.4% | -2.0% | +5.0% | -23.0% | +21.3% | -6.5% | -3.0% | -3.7% | -4.5% | +12.3% | – | |
| – | +1.5% | -0.3% | +4.0% | -1.3% | +7.5% | -6.3% | +1.5% | -0.8% | +1.4% | -1.3% | -1.9% | – | |
| – | +29.0% | +13.3% | -52.1% | -19.6% | +57.1% | -67.8% | +34.2% | -53.2% | +37.6% | -22.4% | +51.7% | – | |
| – | +41.8% | -19.5% | -7.3% | +3.2% | +44.8% | -22.8% | -8.2% | – | – | +17.7% | -7.9% | – | |
| – | +382.7% | -77.4% | -6.8% | -1.6% | +43.0% | -24.3% | -7.1% | -10.0% | +144.4% | -47.8% | -10.3% | – | |
| – | -1,493.2% | – | +69.4% | -0.1% | -108.8% | – | +41.3% | +27.3% | -308.7% | – | +56.5% | – | |
| – | -64.0% | +51.7% | +28.4% | +62.0% | +39.7% | -33.6% | +11.3% | -2.3% | -10.5% | -4.0% | -4.5% | – | |
| – | -1,598.0% | – | +85.3% | -6.3% | -161.1% | – | +7.8% | +106.2% | -490.6% | – | +1,077.3% | – | |
| – | -1,340.9% | – | +242.6% | -59.8% | +210.5% | -75.4% | -12.6% | -299.1% | – | -60.4% | +1,077.5% | – | |
| – | -1,744.2% | – | +17.9% | +60.4% | -277.0% | – | +25.8% | +356.1% | -389.1% | – | +1,077.3% | – | |
| – | -904.8% | – | +64.2% | -174.6% | – | +464.4% | +18.7% | +17.6% | -300.0% | – | +84.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.